BLACK WEEKSFlakoni −15% · komplekti −10% · pārējais −5%ar koduBezmaksas piegāde Vācijā no €200

Šī lapa ir tulkota automātiski un var saturēt kļūdas. Vai latviešu valoda ir jūsu dzimtā valoda? Mēs labprāt saņemsim jūsu atsauksmes un labojumus.Sūtīt atsauksmi

The Peptide Desk The Peptide Desk
Dutasteride, produkta foto

Laboratorijas ziņojums

PDF
Pārbaudīts
Pārbaudīts
Dutasteride 1mg × 100 Tabs
Laboratorija
Analiza Białek
Datums
October 2026
Rezultāts
1.02 mg per tablet (1 mg label)
Pasūtījuma nr.
Parole

Neatkarīgi pārbaudīts, ar paroli pārbaudāms tieši laboratorijā.

Hair & Skin

Dutasteride

Hair & Skin

Pasūtījums

Vienības cena - Bezmaksas piegāde Vācijā no 200 € Black Weeks laikā
  • DHL ar izsekošanu
  • Diskrēts iepakojums

4.6 no 5 Trustpilot73 atsauksmes

Meklēts arī kā: Dutasterid

Īsumā

Dutasteride skaitļos

Galvenie rādītāji no mūsu leksikona. Velciet punktu pa līkni, lai redzētu, cik daudz paliek pēc vienas devas, pēc aprēķina.

Pilns leksikona ieraksts

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~5 weeks

Half-life ~5 weeks
After 10 weeks: 25 %
Week 550 %Week 1025 %Week 1512.5 %Week 253.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

about5weeks

Class
5α-reductase inhibitor type 1 and type 2
Use
Oral1 tablet per day or every other day
Sizes
1 mg1 size in the shop

Zināšanas

Viss par Dutasteride

FAQ

Bieži uzdotie jautājumi

Avoti katrai atbildei: leksikona ieraksts

Vēl ir jautājums?

Rakstiet mums, mūsu komanda jums palīdzēs.

Is dutasteride approved?

Yes. In the USA it has been approved as a prescription drug for the enlarged prostate since 20 November 2001, ChEMBL lists phase 4 as the highest phase. In hereditary hair loss it is used outside this approval, there are phase 3 trials on this.

How does dutasteride differ from finasteride?

Finasteride blocks only 5-alpha reductase type 2, dutasteride both types. In a comparison trial in men with enlarged prostate blood DHT fell by 94.7 percent with the approved dose of dutasteride and by 70.8 percent with finasteride. With finasteride the values also varied much more.

What do the hair loss trials show?

The first trial with 416 men already showed more hair in a dose-dependent way, the highest dose beat finasteride. In a trial with 917 men the approved dose grew more and thicker hairs after 24 weeks than finasteride and placebo. In a Korean phase 3 trial hair count rose by 12.2 per square centimetre in 6 months, on placebo by 4.7. All trials lasted at most 6 months.

What does research show for the prostate?

In three identical trials with 4,325 men the prostate shrank by 25.7 percent in 24 months, symptoms fell by 21.4 percent and urine flow rose. The risk of acute urinary retention fell by 57 percent, of surgery by 48 percent. In the CombAT trial the combination with tamsulosin worked better on symptoms over 4 years than either drug alone.

Does dutasteride lower prostate cancer risk?

In the 4-year REDUCE trial prostate cancer was found less often on dutasteride, 22.8 percent less in relative terms. Aggressive tumours with Gleason 8 to 10, however, were more common in years 3 and 4, 12 against 1. The composite term heart failure was also more common at 0.7 against 0.4 percent.

Which side effects have been described?

In the prostate trials impotence, reduced libido, breast enlargement and ejaculation disorders occurred more often than on placebo, but rarely overall. Except for breast enlargement they became less frequent over time. A meta-analysis in hair loss found a 1.37-fold risk of sexual side effects for dutasteride, not statistically significant. In direct comparison with finasteride there was no clear difference.

Salīdzinājumi

Kā tas atšķiras

Saistītie

Saistītie produkti